Correction of cholinergic deficiency in patients with vascular dementia
https://doi.org/10.14412/2074-2711-2010-82
Abstract
The efficacy of the acetylcholine esterase inhibitor reminil was studied in vascular dementia (VD). Eighty-four (54 men and 30 women) patients aged 60-85 years with the verified diagnosis of VD were followed up. Their mean age was 65±4,3 years; the mean duration of VD after its diagnosis was 2,3 years (that after firstly detected VD was less than 4 years). Primary examination before therapy showed that all the patients had cognitive disorders characteristic of VD concurrent with varying motor disorders. Reminil showed a significant effect against the symptoms of VS within 1,5-2 months after initiation of its administration and when the therapeutic effect of the drug was achieved. Improved cognitive functions were preserved during a 12-month follow-up. Owing to its double mechanism of action, reminil is active against cognitive and behavioral disorders in a wide circle of patients with dementia, well tolerated, and causes no serious adverse reactions.
About the Author
O. I. Mokhova
Treatment and Rehabilitation Center, Russian Agency for Health Care
Russian Federation
Moscow
Russian Federation
Moscow
References
1. <div><p>Международная статистическая классификация болезней и проблем, связанных со здоровьем. Десятый пересмотр (МКБ-10). Женева, 1995;1(1):510-1.</p><p>Вахнина Н.В., Никитина Л.Ю., Парфенов В.А., Яхно Н.Н. Постинсультные когнитивные нарушения. Инсульт 2008; 22: 16-21.</p><p>Madureira S., Guerreiro M., Ferro J.M. Dementia and cognitive impairment three months after stroke. Eur J Neurol 2001; 8(6): 621-7.</p><p>Henon H., Pasquier F., Leys D. Poststroke dementia. Cerebrovasc Dis 2006; 22(1): 61-70.</p><p>Яхно Н.Н., Левин О.С., Дамулин И.В. Сопоставление клинических и МРТ-данных при ддисциркуляторной энцефалопатии. Сообщение 2: Когнитивные нарушения. Неврол. журн. 2001; 6(3): 10-9.</p><p>Altieri M., Di Piero V., Pasquini M. Delayed poststroke dementia: a 4-year follow-up study. Neurology 2004; 62(12): 2193-7.</p><p>Мелентьев А.С., Гасилин В.С., Гусев Е.И. и др. Гериатрические аспекты внутренних болезней. М.: Medi Net, 1995.</p><p>Левин О.С. Диагностика и лечение деменции в клинической практике. М.: Медпресс Информ, 2010.</p><p>Пожилой больной. Сост. Г.Н. Милютина. Петрозаводск: Центр информ.-библ. поддержки здравоохранения, 2003.</p><p>Аксаментов Г.В. Клинические и функциональные особенности пациентов гериатрического стационара. Здравоохранение 2002.</p><p>Левин О.С., Дамулин И.В. Диффузные изменения белого вещества (лейкоареоз) и проблема сосудистой деменции. В кн.: Достижения в нейрогериатрии. Под ред. Н.Н. Яхно, И.В. Дамулина. 1995; 2: 189-231.</p><p>Ritchie C.W. et al. Therapeutic strategies in Dementia. Clinical Publishing. Oxford, 2007.</p><p>Мищенко Т.С. Современные подходы к лечению больных дисциркуляторной энцефалопатией. Киев: Здоров'я України, 2007.</p><p>Roman G. Vascular dementia: Distinguishing characteristics, treatment, and prevention. JAGS 2003; 51: S296-S304.</p><p>Launer L.J., Masaki K., Petrovitch H. et al. The association between midlife blood pressure level and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995; 274(23).</p><p>Roman G.C., Tatemichi T.K., Erkinjuntti T. et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43(2): 250-60.</p><p>Hachinski V. Vascular dementia: a radical redefinition. Dementia 1994; 5(3-4): 130-2.</p><p>Erkinjuntti T., Inzitari D., Pantoni L. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm 2000; 59(Suppl. 2): 23-30.</p><p>Patterson C., Feightner J., Garcia A. General risk factors for dementia: a systematic evidence review. Alzheimers Dement 2007; 3(4).</p><p>Дамулин И.В. Болезнь Альцгеймера и сосудистая деменция. М., 2002.</p><p>Elias M.F., Wolf P.A., D'Agostino R.B. et al. Untreated blood pressure level is inversely reated to cognitive functioning: the Framingham Study. Am J Epidemiol 1993; 138(6): 353-64.</p><p>Ruitenberg A., Skoog I., Ott A. et al. Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord 2001; 12(1): 33-9.</p><p>Захаров В.В. Современные аспекты фармакотерапии деменции. Неврол. журн. 2006; 2.</p><p>Дворецкий Л.И., Кузнецова О.П. Трудности диагностики у лиц пожилого возраста. Тер. арх. 1995; 10: 35-9.</p></div><br />
Review
For citations:
Mokhova OI. Correction of cholinergic deficiency in patients with vascular dementia. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2010;2(2):40-45. (In Russ.) https://doi.org/10.14412/2074-2711-2010-82
Views:
734
Email this article 